HMS Holdings Corp secures stake in MedAdvisor
Baker McKenzie has assisted HMS Holdings Corp in securing a stake in MedAdvisor.
Firm: Baker McKenzie (HMS Holdings Corp)
Deal: Baker McKenzie has acted for Nasdaq-listed HMS Holdings Corp on its 13 per cent stake investment in the ASX-listed MedAdvisor.
Key players: The team was led by head of M&A Richard Lustig, who was assisted by Xavier Keary and Ben McLaughlin.
Deal significance: MedAdvisor offers a software platform to make the management of medication easier. MedAdvisor connects to a patient’s pharmacy to provide them with details of the patient’s medication and prescriptions to make the process effective.
According to HMS Holdings Corp, the investment marks the launch of its strategic partnership with MedAdvisor to tackle the global issues of medication non-adherence.
Mr Lustig said: “The future of healthcare delivery is rapidly evolving to better meet the needs of patients given new technologies underpinned by constant innovation. We were delighted to assist HMS Holdings Corp on this cross-border deal which will meet the strategic needs of their business.”